Genetic and epigenetic alterations of familial pancreatic cancers. - Wikidata - awgldk - TriplyDB

Genetic and epigenetic alterations of familial pancreatic cancers.

Genetic and epigenetic alterations of familial pancreatic cancers.

http://www.wikidata.org/entity/Q37148201

about

SIBLINGs and SPARC families: their emerging roles in pancreatic cancer Thyroid transcription factors in development, differentiation and disease TP53INP1 decreases pancreatic cancer cell migration by regulating SPARC expression Screening for Pancreatic Cancer.Pancreatic cancers epigenetically silence SIP1 and hypomethylate and overexpress miR-200a/200b in association with elevated circulating miR-200a and miR-200b levels Pancreatic adenocarcinoma in type 2 progressive familial intrahepatic cholestasis Lack of host SPARC enhances vascular function and tumor spread in an orthotopic murine model of pancreatic carcinoma.Epigenetics and pancreatic cancer: pathophysiology and novel treatment aspects Methylation of the SPARC gene promoter and its clinical implication in pancreatic cancer.An expression profile analysis of ES cell-derived definitive endodermal cells and Pdx1-expressing cells Pancreatic cancer DNMT1 expression and sensitivity to DNMT1 inhibitors.Current and emerging therapies for the treatment of pancreatic cancer.Novel methylation biomarker panel for the early detection of pancreatic cancer.Molecular analysis of precursor lesions in familial pancreatic cancer New insights into FoxE1 functions: identification of direct FoxE1 targets in thyroid cells Thyroid-specific transcription factors and their roles in thyroid cancer.Familial and sporadic pancreatic cancer share the same molecular pathogenesis.The promise of methylation on beads for cancer detection and treatment.Stool DNA testing for the detection of pancreatic cancer: assessment of methylation marker candidates GSH2 promoter methylation in pancreatic cancer analyzed by quantitative methylation-specific polymerase chain reaction Inhibition of Cell Proliferation and Growth of Pancreatic Cancer by Silencing of Carbohydrate Sulfotransferase 15 In Vitro and in a Xenograft Model.Mutant TP53 in duodenal samples of pancreatic juice from patients with pancreatic cancer or high-grade dysplasia Genome-wide somatic copy number alterations in low-grade PanINs and IPMNs from individuals with a family history of pancreatic cancer Current surgical aspects of palliative treatment for unresectable pancreatic cancer.Genomic sequencing of key genes in mouse pancreatic cancer cells.SPARC: a matricellular regulator of tumorigenesis.Familial pancreatic cancer: Concept, management and issues.Perspectives of TGF-β inhibition in pancreatic and hepatocellular carcinomas.Having pancreatic cancer with tumoral loss of ATM and normal TP53 protein expression is associated with a poorer prognosis.MicroRNA-148b and microRNA-152 reactivate tumor suppressor genes through suppression of DNA methyltransferase-1 gene in pancreatic cancer cell lines.Familial pancreatic cancer and hereditary syndromes: screening strategy for high-risk individuals.Potential epigenetic biomarkers for the diagnosis and prognosis of pancreatic ductal adenocarcinomas.Profiling of embryonic stem cell differentiation.MicroRNA-410 functions as a tumor suppressor by targeting angiotensin II type 1 receptor in pancreatic cancer.ppENK Gene Methylation Status in the Development of Pancreatic Carcinoma.Methylation pattern of oncogene HRAS gene promoter region and its clinical relevance to urocystic tumorigenesis.An Effective Concentration of 5-Aza-CdR to Induce Cell Death and Apoptosis in Human Pancreatic Cancer Cell Line through Reactivating RASSF1A and Up-Regulation of Bax Genes

P2860

Q27027759-A426578A-A556-4716-BC46-39A311EF4A69 Q28250485-26BDA31B-9007-4F72-BB17-844B6C959A11 Q28510298-2FE09E69-F9C5-43FD-8FE1-18EBF974FBA2 Q30240971-F95936C1-27F3-4D98-8B97-296809F1F22C Q30502172-B719C70A-AEA9-4F18-955A-BEAC1C6625EC Q33540358-2E3B45A5-C496-48CC-BEED-1779D4B0C13E Q33592374-8F42C02B-9BD1-40D3-805F-6FE6B6964C17 Q33801377-ED14C8E0-4752-4D24-B730-4B6DF1C35D9B Q33820209-9A322955-30B5-4A3D-B8F8-CBB477247EA5 Q33833119-6A9F6591-B464-43CC-A4C1-A36475AE2E4D Q34061112-C3335B7E-0A92-4239-AD90-D9A900B5FE49 Q34129346-287C6ED4-3ABF-4A5C-B8AF-E1F3EBBA19E5 Q34374959-F9BE4EDB-2DBB-40C4-9897-0815F3A306FD Q34571373-BC10D7FD-C7C3-47CD-8BA1-F227E16067C8 Q34722708-0DEAB4C0-42A4-4781-A5BB-1CCEE40543F3 Q35038884-F8DFA2B5-15C1-4BB6-A6FA-958D05A053AF Q35171140-51685A7F-1293-45CE-BB6B-6E0EBD786B0D Q35594733-D5F37051-CCD4-4F4C-8577-E3209F25FC5B Q35798841-0E756AE7-0460-4872-ACF2-0966D207C9FB Q35803994-A0C73F29-548D-47F8-B54E-BD42FFABEC1C Q35862620-A9F98DCC-827A-48E1-A3D3-99B15C341675 Q36691906-953E8C58-03C8-4C4B-BF36-DB8B9CDCEA7B Q36776802-8BBE5C12-8872-4298-8725-D81E59793AC6 Q37129811-988CC4F7-483D-4665-88D0-E8573B5D698A Q37237804-7B8B14DC-7EAA-4FF8-A159-4EB28C9AAFA7 Q37610020-4684461F-9056-4661-B7B2-2683BC7329EA Q37644011-06ED1949-C3CD-46A9-940A-53DD32057A0D Q37649636-E6430527-4CB9-463E-ABD4-2222B435B04E Q37684554-35A7E42E-B4F5-4698-81DD-DA7698B5E402 Q37692456-038F8C9E-4B2F-40FB-98A9-732FA8D1466D Q37918870-78978616-7AA6-47E5-91CE-4FA04338EFD5 Q38115619-BA1C8301-92D4-4973-8AA1-97440C69553B Q38242273-4C46371A-8AF8-4775-AE4C-72410EE00237 Q38913514-DE125034-337D-4F0F-98B1-E65E122662D3 Q41790724-5AEC1310-0D27-4FC8-B284-36F3C28A90FE Q45364229-7E252463-8F62-407E-85E7-F27C34FF8606 Q58776397-F92A1BB6-D21A-4DED-A0D3-64929D4B0A21

P2860

Genetic and epigenetic alterations of familial pancreatic cancers.

http://www.wikidata.org/entity/Q37148201

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Genetic and epigenetic alterations of familial pancreatic cancers.

@en

Genetic and epigenetic alterations of familial pancreatic cancers.

@nl

type

label

Genetic and epigenetic alterations of familial pancreatic cancers.

@en

Genetic and epigenetic alterations of familial pancreatic cancers.

@nl

prefLabel

Genetic and epigenetic alterations of familial pancreatic cancers.

@en

Genetic and epigenetic alterations of familial pancreatic cancers.

@nl

P1433

Q37148201-93D1991C-DAB6-436C-BFE5-6DE326F8AF8C

P1476

Q37148201-426B571B-CEB7-4962-BD82-35DD7FC3D8A0

P2093

Q37148201-50BCFD96-CE02-4EEC-A8AC-34F886B0D9F3

Q37148201-740A7E98-CDC0-4075-A892-0E38C1411395

Q37148201-7C1FDF74-7BA4-4410-A1F9-44B08D277848

Q37148201-81CFBAB6-68B3-432D-8541-939026436392

Q37148201-94A56109-DFBA-4983-831F-F02E9C36CDFD

Q37148201-9CC77898-6236-47A3-BEF9-3C8C6C1B500A

Q37148201-A54962FA-4F91-4A9C-A7A9-D4DE878F7FC3

Q37148201-ADFFD85B-DA03-4188-B231-E9704E46CE16

Q37148201-B72D3C65-062C-4855-AAA1-61FBBF9E5BB3

Q37148201-CA751261-93ED-4B73-A973-A50D109B3A8A

P2860

Q37148201-02865E6A-A617-47C6-A77C-F7F7EE2F8219

Q37148201-02AFD737-6543-4B64-B8A2-E5E0BCAB3C9A

Q37148201-06BE9A5D-D15D-4A56-AE0B-6D161E8E586D

Q37148201-099A5D0B-2B57-41E8-AE82-2AB4BB5A2484

Q37148201-0C36D782-BD6C-4A3B-B7FE-4C464A68CC01

Q37148201-1894FC47-E5B6-49BC-B580-0EF8EB9384AC

Q37148201-1A238CC5-B5B0-4A1F-B172-363389DBC564

Q37148201-23EC0542-7D9B-4D8D-BD50-DB0BD6DD5EB4

Q37148201-25226734-2673-4E45-BA90-1604B48DDE2B

Q37148201-2C1ED044-5B3D-444C-9EC3-AD085165F321

P304

Q37148201-AA62EC05-0CBA-483A-B2FF-D92D84EF6959

P31

Q37148201-27EFD72B-BFDA-40DD-AA85-BB9E5E59E75B

P356

Q37148201-A5DB68E6-9235-4A6F-AFAE-7B28A37DD777

P433

Q37148201-5477223E-BC33-4C46-A3DF-8F7F48599D21

P478

Q37148201-2C6A814F-41D1-450A-BCE5-FFD9D6924E4F

P50

Q37148201-29788C28-CE55-4564-A846-7AF92FFC8D02

Q37148201-D3C325C3-6BE6-441A-9784-4B651698C2D8

Q37148201-D3CE312C-53C9-47D4-B94B-994BB55542D8

P577

Q37148201-AB479D3A-95AD-4FD6-BC0F-0629BAA392C9

P5875

Q37148201-78DFD6CB-1E4B-40B9-BA92-328FF5E56012

P698

Q37148201-564F063B-72EA-404D-B598-9EB4A2F10B48

P932

Q37148201-4401642E-9727-4FA0-9D7A-7A75D5352D71

P356

1055-9965.EPI-08-0630

P1433

Cancer Epidemiology, Biomarkers & Prevention

P1476

Genetic and epigenetic alterations of familial pancreatic cancers.

@en

P2093

Alison P Klein

http://www.w3.org/2001/XMLSchema#string

Ang Li

http://www.w3.org/2001/XMLSchema#string

Christine Iacobuzio-Donohue

http://www.w3.org/2001/XMLSchema#string

Dawei Yang

http://www.w3.org/2001/XMLSchema#string

James Eshleman

http://www.w3.org/2001/XMLSchema#string

Kieran Brune

http://www.w3.org/2001/XMLSchema#string

Marcia Canto

http://www.w3.org/2001/XMLSchema#string

Margaret Griffith

http://www.w3.org/2001/XMLSchema#string

Noriyuki Omura

http://www.w3.org/2001/XMLSchema#string

Rich Schulick

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2008

The epigenomics of cancer

p53 mutations in human cancers

DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1

Genome-wide allelotypes of familial pancreatic adenocarcinomas and familial and sporadic intraductal papillary mucinous neoplasms.

Differential and epigenetic gene expression profiling identifies frequent disruption of the RELN pathway in pancreatic cancers.

Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis.

p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions.

An introduction to pancreatic adenocarcinoma genetics, pathology and therapy.

Genetics of the FANCA gene in familial pancreatic cancer

P304

3536-3542

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1055-9965.EPI-08-0630

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

Ralph H. Hruban

Michael Goggins

P577

2008-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23639954

http://www.w3.org/2001/XMLSchema#string

P698

19064568

http://www.w3.org/2001/XMLSchema#string

P932

2664523

http://www.w3.org/2001/XMLSchema#string